OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Immunological Mechanisms and Immune-Based Biomarkers of Drug-Induced Liver Injury
Wenhui Liu, Xiangchang Zeng, Yating Liu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 25
Wenhui Liu, Xiangchang Zeng, Yating Liu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 25
Showing 25 citing articles:
The Hepatoprotective and Hepatotoxic Roles of Sex and Sex-Related Hormones
Linlin Xu, Yuan Yuan, Zhaodi Che, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41
Linlin Xu, Yuan Yuan, Zhaodi Che, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41
Analysis of Immunometabolic Profiles in Patients With Chronic Drug‐Induced Liver Injury and Validation in Mice to Reveal Potential Mechanisms
Xingran Zhai, Xian He, Ang Huang, et al.
Journal of Gastroenterology and Hepatology (2025)
Closed Access
Xingran Zhai, Xian He, Ang Huang, et al.
Journal of Gastroenterology and Hepatology (2025)
Closed Access
Ursodeoxycholic Acid for the Management of Drug-induced Liver Injury: Role of Hepatoprotective and Anti-cholestatic Mechanisms
Fernando Bessone, Geraldine L. Hillotte, Norberto Tamagnone, et al.
Journal of Clinical and Translational Hepatology (2025) Vol. 000, Iss. 000, pp. 000-000
Open Access
Fernando Bessone, Geraldine L. Hillotte, Norberto Tamagnone, et al.
Journal of Clinical and Translational Hepatology (2025) Vol. 000, Iss. 000, pp. 000-000
Open Access
Drug-Induced Liver Injury—Pharmacological Spectrum Among Children
Bianca Raluca Maris, Alina Grama, Tudor Lucian Pop
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2006-2006
Open Access
Bianca Raluca Maris, Alina Grama, Tudor Lucian Pop
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2006-2006
Open Access
The Dual Role of Innate Immune Response in Acetaminophen-Induced Liver Injury
Tao Yang, Han Wang, Xiao Wang, et al.
Biology (2022) Vol. 11, Iss. 7, pp. 1057-1057
Open Access | Times Cited: 23
Tao Yang, Han Wang, Xiao Wang, et al.
Biology (2022) Vol. 11, Iss. 7, pp. 1057-1057
Open Access | Times Cited: 23
An Immunological Perspective on the Mechanism of Drug Induced Liver Injury: Focused on Drugs for Treatment of Hepatocellular Carcinoma and Liver Transplantation
Soon Kyu Lee, Jong Young Choi, Eun Sun Jung, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 5002-5002
Open Access | Times Cited: 13
Soon Kyu Lee, Jong Young Choi, Eun Sun Jung, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 5002-5002
Open Access | Times Cited: 13
Human Leucocyte Antigen Genetics in Idiosyncratic Drug-Induced Liver Injury with Evidence Based on the Roussel Uclaf Causality Assessment Method
Rolf Teschke, Gaby Danan
Medicines (2024) Vol. 11, Iss. 4, pp. 9-9
Open Access | Times Cited: 4
Rolf Teschke, Gaby Danan
Medicines (2024) Vol. 11, Iss. 4, pp. 9-9
Open Access | Times Cited: 4
Modeling drug-induced liver injury: current status and future prospects
Daniel E. Di Zeo-Sánchez, Antonio Segovia-Zafra, Gonzalo Matilla‐Cabello, et al.
Expert Opinion on Drug Metabolism & Toxicology (2022) Vol. 18, Iss. 9, pp. 555-573
Open Access | Times Cited: 14
Daniel E. Di Zeo-Sánchez, Antonio Segovia-Zafra, Gonzalo Matilla‐Cabello, et al.
Expert Opinion on Drug Metabolism & Toxicology (2022) Vol. 18, Iss. 9, pp. 555-573
Open Access | Times Cited: 14
Molecular docking and dynamics guided approach to identify potential anti-inflammatory molecules as NRF2 activator to protect against drug-induced liver injury (DILI): a computational study
Ajay Mili, Subham Das, Krishnadas Nandakumar, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 19, pp. 9193-9210
Closed Access | Times Cited: 13
Ajay Mili, Subham Das, Krishnadas Nandakumar, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 19, pp. 9193-9210
Closed Access | Times Cited: 13
Unveiling the therapeutic promise of natural products in alleviating drug‐induced liver injury: Present advancements and future prospects
Deepti Singh, Mohammad Afsar Khan, Hifzur R. Siddique
Phytotherapy Research (2023) Vol. 38, Iss. 1, pp. 22-41
Closed Access | Times Cited: 7
Deepti Singh, Mohammad Afsar Khan, Hifzur R. Siddique
Phytotherapy Research (2023) Vol. 38, Iss. 1, pp. 22-41
Closed Access | Times Cited: 7
Immuno-inflammatory in vitro hepatotoxicity models to assess side effects of biologicals exemplified by aldesleukin
Luise A. Roser, Sonja Luckhardt, Nicole Ziegler, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Luise A. Roser, Sonja Luckhardt, Nicole Ziegler, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Sex disparity and drug-induced liver injury
Annarosa Floreani, Debora Bizzaro, Sarah Shalaby, et al.
Digestive and Liver Disease (2022) Vol. 55, Iss. 1, pp. 21-28
Closed Access | Times Cited: 9
Annarosa Floreani, Debora Bizzaro, Sarah Shalaby, et al.
Digestive and Liver Disease (2022) Vol. 55, Iss. 1, pp. 21-28
Closed Access | Times Cited: 9
Gut Microbiota and Drug-Related Liver Injury: Challenges and Perspectives
Yuanyuan Su, Ning Lü, Qian Li, et al.
Advanced Gut & Microbiome Research (2023) Vol. 2023, pp. 1-9
Open Access | Times Cited: 4
Yuanyuan Su, Ning Lü, Qian Li, et al.
Advanced Gut & Microbiome Research (2023) Vol. 2023, pp. 1-9
Open Access | Times Cited: 4
Autoimmunity associates with severity of illness in elderly patients with drug-induced liver injury
Yüting Xiong, Jianfei Wang, Xiaoxia Niu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Yüting Xiong, Jianfei Wang, Xiaoxia Niu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
A computational study to identify Sesamol derivatives as NRF2 activator for protection against drug-induced liver injury (DILI)
Ajay Mili, Sumit Birangal, Krishnadas Nandakumar, et al.
Molecular Diversity (2023) Vol. 28, Iss. 3, pp. 1709-1731
Open Access | Times Cited: 4
Ajay Mili, Sumit Birangal, Krishnadas Nandakumar, et al.
Molecular Diversity (2023) Vol. 28, Iss. 3, pp. 1709-1731
Open Access | Times Cited: 4
Chemotherapy-Induced Liver Injury: Unveiling Emerging Mechanisms and Exploring Mitigation Strategies
Mahmoud Alkabbani, Abdel-Aziz Shatat, Aliaa Ghazy, et al.
Deleted Journal (2024)
Open Access
Mahmoud Alkabbani, Abdel-Aziz Shatat, Aliaa Ghazy, et al.
Deleted Journal (2024)
Open Access
Innate immune regulation in inflammation resolution and liver regeneration in drug-induced liver injury
Yihan Qian, Jie Zhao, Hailong Wu, et al.
Archives of Toxicology (2024)
Closed Access
Yihan Qian, Jie Zhao, Hailong Wu, et al.
Archives of Toxicology (2024)
Closed Access
Mécanismes de l’hépatotoxicité médicamenteuse
Lucy Meunier, Emilie Malézieux, P. Rivière, et al.
EMC - Hépatologie (2024) Vol. 39, Iss. 1, pp. 1-9
Closed Access
Lucy Meunier, Emilie Malézieux, P. Rivière, et al.
EMC - Hépatologie (2024) Vol. 39, Iss. 1, pp. 1-9
Closed Access
Activation of cDCs and iNKT cells contributes to triptolide-induced hepatotoxicity via STING signaling pathway and endoplasmic reticulum stress
Xin Chen, Zixun Yu, Nong Cheng, et al.
Cell Biology and Toxicology (2022) Vol. 39, Iss. 4, pp. 1753-1772
Closed Access | Times Cited: 3
Xin Chen, Zixun Yu, Nong Cheng, et al.
Cell Biology and Toxicology (2022) Vol. 39, Iss. 4, pp. 1753-1772
Closed Access | Times Cited: 3
Toxoplasma gondii IST suppresses inflammatory and apoptotic responses by inhibiting STAT1-mediated signaling in IFN-γ/TNF-α-stimulated hepatocytes
Seung‐Hwan Seo, Ji‐Eun Lee, Do-Won Ham, et al.
Parasites Hosts and Diseases (2024) Vol. 62, Iss. 1, pp. 30-41
Open Access
Seung‐Hwan Seo, Ji‐Eun Lee, Do-Won Ham, et al.
Parasites Hosts and Diseases (2024) Vol. 62, Iss. 1, pp. 30-41
Open Access
Immunology of the Liver
Yousef Maali, Thomas Fabre, Naglaa H. Shoukry
Elsevier eBooks (2024)
Closed Access
Yousef Maali, Thomas Fabre, Naglaa H. Shoukry
Elsevier eBooks (2024)
Closed Access
Drug-induced liver injury caused by conventional drugs, using cases based on the Roussel Uclaf causality assessment method
Nahúm Méndez‐Sánchez, Rolf Teschke
Elsevier eBooks (2023), pp. 385-407
Closed Access | Times Cited: 1
Nahúm Méndez‐Sánchez, Rolf Teschke
Elsevier eBooks (2023), pp. 385-407
Closed Access | Times Cited: 1
Toxic hepatitis-associated aplastic anaemia after dual homeopathic remedies and Gymnema sylvestre use
Cyriac Abby Philips, Arif Hussain Theruvath, Resmi Ravindran
BMJ Case Reports (2022) Vol. 15, Iss. 3, pp. e247867-e247867
Open Access | Times Cited: 2
Cyriac Abby Philips, Arif Hussain Theruvath, Resmi Ravindran
BMJ Case Reports (2022) Vol. 15, Iss. 3, pp. e247867-e247867
Open Access | Times Cited: 2
Immunophenotyping to improve the mechanistic understanding of idiosyncratic drug-induced liver injury: clinical implications and future directions
Alejandro Cueto‐Sánchez, Daniel E. Di Zeo-Sánchez, Antonio Segovia-Zafra, et al.
(2023), pp. 56-76
Open Access
Alejandro Cueto‐Sánchez, Daniel E. Di Zeo-Sánchez, Antonio Segovia-Zafra, et al.
(2023), pp. 56-76
Open Access
MicroRNA-181a-5p alleviates acute liver failure in mice by inhibiting HMGB1
Qianwen Zhang, Yiyu He, Hao Xu, et al.
Cellular and Molecular Biology (2023) Vol. 69, Iss. 9, pp. 130-135
Open Access
Qianwen Zhang, Yiyu He, Hao Xu, et al.
Cellular and Molecular Biology (2023) Vol. 69, Iss. 9, pp. 130-135
Open Access
